Jeffrey S. Heier, Chief Officer of Ocular Therapeutix OCUL, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $207.8K. The latest trade was on 05/26.

JH

JH

Jeffrey S. Heier

Chief Scientific Officer

Company

Ocular Therapeutix OCUL

First filing

23/06/16

Trades

15 trades

Buys / sales

0 / 8

12-month net buying

−$207.8K

Last trade

05/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	05/26	05/28	3,018 sh	$8.20	$24,747.6	−0.9%
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	02/23	02/25	3,057 sh	$8.28	$25,311.96	−0.9%
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	25/11/24	25/11/26	3,469 sh	$12.04	$41,766.76	−1.4%
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	25/10/02	25/10/06	10,502 sh	$11.04	$115,942.08	−4.0%
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	25/08/25	25/08/27	3,063 sh	$12.04	$36,878.52	−1.2%
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	25/05/23	25/05/27	3,024 sh	$7.18	$21,712.32	−1.1%
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	25/02/24	25/02/26	3,061 sh	$6.87	$21,029.07	−1.1%
Ocular TherapeutixOCUL	Open-market sale10b5-1 plan	24/11/25	24/11/27	2,948 sh	$9.01	$26,561.48	−1.1%